HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chun Changou Selected Research

2- (dibenzo(b,d)furan- 2- yl)- 7- phenyl- 1- (3- (piperidin- 1- yl)propyl)- 1H- imidazo(4,5- g)quinoxalin- 6(5H)- one

1/2013CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chun Changou Research Topics

Disease

1Neoplasm Metastasis (Metastasis)
01/2013
1Prostatic Neoplasms (Prostate Cancer)
01/2013

Drug/Important Bio-Agent (IBA)

12- (dibenzo(b,d)furan- 2- yl)- 7- phenyl- 1- (3- (piperidin- 1- yl)propyl)- 1H- imidazo(4,5- g)quinoxalin- 6(5H)- oneIBA
01/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2013
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2013